Variant report
Variant | nsv979895 |
---|---|
Chromosome Location | chr3:160664994-160666094 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs556123022 | chr3:160665037-160665038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs552142719 | chr3:160665042-160665043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs374090193 | chr3:160665051-160665052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs386667631 | chr3:160665065-160665066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs62280309 | chr3:160665076-160665077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557087785 | chr3:160665114-160665115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs576826165 | chr3:160665121-160665122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs377277004 | chr3:160665193-160665194 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs536351545 | chr3:160665278-160665279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs570658048 | chr3:160665291-160665292 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs192569209 | chr3:160665327-160665328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs572975036 | chr3:160665338-160665339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs150065964 | chr3:160665380-160665381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs561684061 | chr3:160665403-160665404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs539784749 | chr3:160665411-160665412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs144375680 | chr3:160665440-160665441 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs564331000 | chr3:160665470-160665471 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs533429220 | chr3:160665501-160665502 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs112335899 | chr3:160665519-160665520 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs115547826 | chr3:160665608-160665609 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
21 | rs535505781 | chr3:160665629-160665630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs13073571 | chr3:160665720-160665721 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs549688730 | chr3:160665752-160665753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs113362232 | chr3:160665759-160665760 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs538540677 | chr3:160665797-160665798 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs536716734 | chr3:160665811-160665812 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs533870160 | chr3:160665846-160665847 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs148771627 | chr3:160665872-160665873 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs183684771 | chr3:160665930-160665931 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs539492239 | chr3:160666000-160666001 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16608533 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Bladder cancer | 21909424 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 21811512 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:160658800-160667400 | Weak transcription | Thymus | Thymus |
2 | chr3:160659800-160666000 | Weak transcription | Fetal Kidney | kidney |
3 | chr3:160663400-160666200 | Weak transcription | Psoas Muscle | Psoas |
4 | chr3:160664000-160665800 | Weak transcription | Liver | Liver |
5 | chr3:160665800-160666600 | Enhancers | Fetal Intestine Large | intestine |
6 | chr3:160665800-160666800 | Enhancers | Liver | Liver |
7 | chr3:160666000-160666200 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
8 | chr3:160666000-160666200 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
9 | chr3:160666000-160666400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
10 | chr3:160666000-160666600 | Enhancers | H9 Cell Line | embryonic stem cell |
11 | chr3:160666000-160667400 | Enhancers | Fetal Kidney | kidney |
12 | chr3:160666000-160668000 | Enhancers | HepG2 | liver |